These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Sepsis-induced muscle proteolysis is prevented by a proteasome inhibitor in vivo. Fischer D; Gang G; Pritts T; Hasselgren PO Biochem Biophys Res Commun; 2000 Apr; 270(1):215-21. PubMed ID: 10733930 [TBL] [Abstract][Full Text] [Related]
23. Rosuvastatin attenuates hypertension-induced cardiovascular remodeling without affecting blood pressure in DOCA-salt hypertensive rats. Loch D; Levick S; Hoey A; Brown L J Cardiovasc Pharmacol; 2006 Mar; 47(3):396-404. PubMed ID: 16633082 [TBL] [Abstract][Full Text] [Related]
24. Effect of a methionine-supplemented diet on the blood pressure of Sprague-Dawley and deoxycorticosterone acetate-salt hypertensive rats. Robin S; Maupoil V; Laurant P; Jacqueson A; Berthelot A Br J Nutr; 2004 Jun; 91(6):857-65. PubMed ID: 15182389 [TBL] [Abstract][Full Text] [Related]
25. 5-Hydroxytryptamine lowers blood pressure in normotensive and hypertensive rats. Diaz J; Ni W; Thompson J; King A; Fink GD; Watts SW J Pharmacol Exp Ther; 2008 Jun; 325(3):1031-8. PubMed ID: 18305011 [TBL] [Abstract][Full Text] [Related]
26. Role of gp91phox-containing NADPH oxidase in the deoxycorticosterone acetate-salt-induced hypertension. Fujii A; Nakano D; Katsuragi M; Ohkita M; Takaoka M; Ohno Y; Matsumura Y Eur J Pharmacol; 2006 Dec; 552(1-3):131-4. PubMed ID: 17064681 [TBL] [Abstract][Full Text] [Related]
27. Effect of a nonselective endothelin antagonist on vascular remodeling in deoxycorticosterone acetate-salt hypertensive rats. Evidence for a role of endothelin in vascular hypertrophy. Li JS; Larivière R; Schiffrin EL Hypertension; 1994 Aug; 24(2):183-8. PubMed ID: 8039842 [TBL] [Abstract][Full Text] [Related]
28. Gene transfer of human guanosine 5'-triphosphate cyclohydrolase I restores vascular tetrahydrobiopterin level and endothelial function in low renin hypertension. Zheng JS; Yang XQ; Lookingland KJ; Fink GD; Hesslinger C; Kapatos G; Kovesdi I; Chen AF Circulation; 2003 Sep; 108(10):1238-45. PubMed ID: 12925450 [TBL] [Abstract][Full Text] [Related]
29. Effect of exercise training on liver antioxidant status of deoxycorticosterone acetate salt induced hypertensive rats. Elhaïmeur F; Courderot-Masuyer C; Nicod L; Bobillier-Chaumont S; Robin S; Richert L; Berthelot A Can J Physiol Pharmacol; 2003 May; 81(5):469-75. PubMed ID: 12774853 [TBL] [Abstract][Full Text] [Related]
30. Magnesium supplementation and deoxycorticosterone acetate--salt hypertension: effect on arterial mechanical properties and on activity of endothelin-1. Berthon N; Laurant P; Hayoz D; Fellmann D; Brunner HR; Berthelot A Can J Physiol Pharmacol; 2002 Jun; 80(6):553-61. PubMed ID: 12117304 [TBL] [Abstract][Full Text] [Related]
31. Vasopressin induces vascular superoxide via endothelin-1 in mineralocorticoid hypertension. Li L; Galligan JJ; Fink GD; Chen AF Hypertension; 2003 Mar; 41(3 Pt 2):663-8. PubMed ID: 12623976 [TBL] [Abstract][Full Text] [Related]
32. Blood pressure variability, cardiac baroreflex sensitivity and organ damage in experimentally hypertensive rats. Wang DS; Xie HH; Shen FM; Cai GJ; Su DF Clin Exp Pharmacol Physiol; 2005 Jul; 32(7):545-52. PubMed ID: 16026514 [TBL] [Abstract][Full Text] [Related]
33. Deoxycorticosterone acetate plus salt induces overexpression of vascular endothelin-1 and severe vascular hypertrophy in spontaneously hypertensive rats. Schiffrin EL; Larivière R; Li JS; Sventek P; Touyz RM Hypertension; 1995 Apr; 25(4 Pt 2):769-73. PubMed ID: 7721430 [TBL] [Abstract][Full Text] [Related]
34. Antihypertensive effect of sesamin. I. Protection against deoxycorticosterone acetate-salt-induced hypertension and cardiovascular hypertrophy. Matsumura Y; Kita S; Morimoto S; Akimoto K; Furuya M; Oka N; Tanaka T Biol Pharm Bull; 1995 Jul; 18(7):1016-9. PubMed ID: 7581242 [TBL] [Abstract][Full Text] [Related]
35. Chronic treatment with mianserin prevents DOCA-salt hypertension in rats--evidence for the involvement of central 5-HT2 receptors. Silva AL; Cabral AM; Abreu GR; Pires JG; Bissoli NS; Ramage AG Eur J Pharmacol; 2005 Aug; 518(2-3):152-7. PubMed ID: 16014306 [TBL] [Abstract][Full Text] [Related]